The impact of hormonal contraception on disease-related cyclical symptoms in women with inflammatory bowel diseases

Inflammatory Bowel Diseases

Volumn 20, Issue 10, 2014, Pages 1729-1733

  Gawron, Lori M ^a   Goldberger, Adina ^a   Gawron, Andrew J ^a   Hammond, Cassing ^a   Keefer, Laurie ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Crohn's disease; Menstruation; Ulcerative colitis

Indexed keywords

CONTRACEPTIVE AGENT; ESTROGEN; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CAUCASIAN; CONTRACEPTIVE BEHAVIOR; CONTROLLED STUDY; CROHN DISEASE; DATA BASE; FEMALE; HORMONAL CONTRACEPTION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTRAUTERINE CONTRACEPTIVE DEVICE; MENSTRUAL CYCLE; PREGNANCY; PRIORITY JOURNAL; REPRODUCTIVE HISTORY; TELEPHONE INTERVIEW; ULCERATIVE COLITIS; CROSS-SECTIONAL STUDY; DRUG EFFECTS; FOLLOW UP; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; YOUNG ADULT;

ADULT; COLITIS, ULCERATIVE; CONTRACEPTIVES, ORAL, HORMONAL; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; PREGNANCY; PROGNOSIS; YOUNG ADULT;

EID: 84925731915     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000134     Document Type: Article

References (21)

1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46-54.
2. Bernstein CN, Singh S, Graff LA, et al. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2010;105:1994-2002.
3. Pedersen N, Bortoli A, Duricova D, et al. The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther. 2013;38:501-512.
4. Iglesias-Rey M, Barreiro-De Acosta M, Caamano-Isorna F, et al. Psychological factors are associated with changes in the health-related quality of life in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:92-102.
5. Keefer L, Taft TH, Kiebles JL, et al. Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther. 2013;38:761-771.
6. Kane SV, Sable K, Hanauer SB. The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol. 1998;93:1867-1872.
7. Parlak E, Da ÄYli U, Alkim C, et al. Pattern of gastrointestinal and psychosomatic symptoms across the menstrual cycle in women with inflammatory bowel disease. Turk J Gastroenterol. 2003;14:250-256.
8. Saha S, Zhao YQ, Shah SA, et al. Menstrual cycle changes in women with inflammatory bowel disease: a study from the ocean state Crohn's and colitis area registry. Inflamm Bowel Dis. 2014;20:534-540.
9. Lim SM, Nam CM, Kim YN, et al. The effect of the menstrual cycle on inflammatory bowel disease: a prospective study. Gut Liver. 2013;7:51-57.
10. Bernstein MT, Graff LA, Targownik LE, et al. Gastrointestinal symptoms before and during menses in women with IBD. Aliment Pharmacol Ther. 2012;36:135-144.
11. Calhoun A, Ford S. Elimination of menstrual-related migraine beneficially impacts chronification and medication overuse. Headache. 2008;48:1186-1193.
12. Herzog AG. Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology. 1986;36:1607-1610.
13. Davis L, Kennedy SS, Moore J, et al. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev. 2007; CD001019.
14. Jones RK. Beyond birth control: the overlooked benefits of oral contraceptive pills. Guttmacher Institute. November 2011. Available at: http://www.guttmacher.org/pubs/Beyond-Birth-Control.pdf. Accessed May 1, 2014.
15. U. S. medically eligibility criteria for contraceptive use. Centers for Disease Control 2010. Available at: http://www.cdc.gov/mmwr/pdf/rr/rr5904.pdf. Accessed April 14, 2014.
16. Gawron LM, Gawron AJ, Kasper A, et al. Contraceptive method selection by women with inflammatory bowel diseases: a cross-sectional survey. Contraception. 2014;89:419-425.
17. Marri SR, Ahn C, Buchman AL. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:591-599.
18. Riis L, Vind I, Politi P, et al. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol. 2006;101:1539-1545.
19. Fonager K, Sorensen HT, Olsen J, et al. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenterol. 1998;93:2426-2430.
20. Norgard B, Fonager K, Sorensen HT, et al. Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am J Gastroenterol. 2000;95:3165-3170.
21. Fisher WA, Black A. Contraception in Canada: a review of method choices, characteristics, adherence and approaches to counselling. CMAJ. 2007;176:953-961.